STARLIGHT THERAPEUTICS Trademark

Trademark Overview

On Saturday, February 11, 2023, a trademark application was filed for STARLIGHT THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the STARLIGHT THERAPEUTICS trademark a serial number of 97790983. The federal status of this trademark filing is EX PARTE APPEAL PENDING as of Tuesday, February 11, 2025. This trademark is owned by STARLIGHT THERAPEUTICS INC.. The STARLIGHT THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development services in the field of oncology, namely, neuro and central nervous system oncology; pharmaceutical drug discovery services in the field of oncology; scientific and medical research and development for pharmaceuticals, pharmaceutical preparations and substances in the field of oncology, namely, neuro and central nervous system oncology
starlight therapeutics

General Information

Serial Number97790983
Word MarkSTARLIGHT THERAPEUTICS
Filing DateSaturday, February 11, 2023
Status760 - EX PARTE APPEAL PENDING
Status DateTuesday, February 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

NOT AVAILABLETHERAPEUTICS
Goods and ServicesPharmaceutical research and development services in the field of oncology, namely, neuro and central nervous system oncology; pharmaceutical drug discovery services in the field of oncology; scientific and medical research and development for pharmaceuticals, pharmaceutical preparations and substances in the field of oncology, namely, neuro and central nervous system oncology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 2, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSTARLIGHT THERAPEUTICS INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDallas, TX 75201

Trademark Events

Event DateEvent Description
Thursday, March 2, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 15, 2023NEW APPLICATION ENTERED
Thursday, November 9, 2023ASSIGNED TO EXAMINER
Tuesday, November 14, 2023NON-FINAL ACTION E-MAILED
Tuesday, November 14, 2023NON-FINAL ACTION WRITTEN
Tuesday, November 14, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 14, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 14, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 14, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 3, 2024FINAL REFUSAL WRITTEN
Wednesday, July 3, 2024FINAL REFUSAL E-MAILED
Wednesday, February 14, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, February 14, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, July 3, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, October 17, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, February 4, 2025ASSIGNED TO PETITION STAFF
Thursday, October 17, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, December 17, 2024TEAS PETITION TO REVIVE RECEIVED
Tuesday, December 17, 2024EXPARTE APPEAL RECEIVED AT TTAB
Saturday, January 18, 2025EXPARTE APPEAL RECEIVED AT TTAB
Thursday, February 6, 2025NOTICE OF REVIVAL - E-MAILED
Thursday, February 6, 2025PETITION GRANTED - TTAB APPEAL FILED
Tuesday, February 11, 2025JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, February 11, 2025EX PARTE APPEAL-INSTITUTED

Related Keywords

therapeutics starlight oncology field pharmaceutical nervous system neuro central namely development research